Welcome to our dedicated page for AMERICAN HEALTHCARE REIT SEC filings (Ticker: AHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for American Healthcare REIT, Inc. (NYSE: AHR), a healthcare-focused real estate investment trust. As an issuer with common stock registered under Section 12(b) of the Securities Exchange Act of 1934, American Healthcare REIT files current reports on Form 8-K and other documents that disclose material events, financial results, capital markets transactions, governance matters and distribution declarations.
In its Form 8-K filings, the company reports quarterly earnings releases and supplemental financial data, including metrics such as GAAP net income attributable to controlling interest, Normalized Funds from Operations (NFFO) per diluted share and Same-Store Net Operating Income (NOI) growth by segment. Filings also describe acquisition and development activity across its integrated senior health campuses (ISHC), outpatient medical, triple-net leased properties and senior housing operating properties (SHOP) segments, as well as lease buyouts and dispositions of non-core properties.
American Healthcare REIT’s SEC filings further detail capital markets activity, such as public offerings of common stock on a forward basis, at-the-market (ATM) equity offering programs and related underwriting and forward sale agreements. The company discloses how it intends to contribute net proceeds to its operating partnership for general corporate purposes, including potential future investments. Additional filings report on quarterly cash distributions authorized by the board of directors, annual meeting voting results, equity plans and corporate responsibility reporting.
On Stock Titan, AI-powered tools can help interpret these filings by summarizing key terms, highlighting segment-level performance disclosures and clarifying the implications of equity offerings, distributions and governance actions. This allows readers to review American Healthcare REIT, Inc.’s regulatory history and understand how the company describes its financial condition, portfolio management and capital structure in official SEC documents.
Form 4 overview: On June 25, 2025, American Healthcare REIT, Inc. (ticker AHR) granted Director Wilbur H. Smith III an equity award of 3,042 shares of restricted common stock in conjunction with his re-election to the board.
Key transaction terms:
- Type: Equity grant (restricted stock); reported as an “A” (acquired) transaction code.
- Price: $0 per share, indicating a non-cash, board-approved compensation grant.
- Vesting: Shares vest in full on June 25, 2026, creating a one-year lock-in that aligns director incentives with shareholder value over the next 12 months.
Ownership impact: Following the award, Smith’s total beneficial ownership increased to 32,419 common shares. The grant adds approximately 3,000 shares, modestly expanding his stake and signalling continued board-level alignment with the company’s long-term performance.
Materiality: The filing represents routine director compensation and does not disclose any open-market purchases or sales, option exercises, or derivative activity. No earnings data, financial guidance, or strategic transactions are included in this report.
American Healthcare REIT, Inc. (AHR) filed a Form 4 disclosing that director Valerie Richardson received an equity grant on 25 June 2025.
- Transaction: 3,042 shares of restricted common stock were awarded (coded “A”) at a price of $0.
- Vesting schedule: The shares vest in full on 25 June 2026.
- Post-transaction ownership: Richardson now beneficially owns 18,062 common shares, held directly.
The filing reflects routine board compensation rather than an open-market purchase. While it slightly increases insider ownership, the size of the award is modest and does not materially change overall share count or insider control.
American Healthcare REIT, Inc. (AHR) – Form 4 insider filing
Director Dianne Hurley received 3,042 restricted shares of AHR common stock on 25 Jun 2025 upon her re-election to the board. The grant was recorded at $0 cost and will vest on 25 Jun 2026. Following this award, Hurley’s direct beneficial ownership increased to 31,443 shares. No shares were sold or transferred, and no derivative securities were involved. The transaction was coded “A,” indicating a stock award rather than an open-market purchase or sale.
The filing reflects routine board compensation, resulting in minor dilution and a modest increase in insider ownership.
American Healthcare REIT, Inc. (AHR) – Form 4 insider filing
Director Brian J. Flornes reported the receipt of 3,042 shares of restricted common stock on 25 June 2025 following his re-election to the board. The grant was recorded under transaction code “A” (acquisition) at an assigned price of $0.00, indicating a non-cash equity award rather than an open-market purchase.
The awarded shares will vest on 25 June 2026, one year after the grant date. After the transaction, Mr. Flornes’ total direct beneficial ownership increased to 30,426 common shares. No derivative securities, dispositions, or sales were reported.
This filing represents a routine director compensation grant and does not introduce new debt, equity financing, or earnings guidance. The transaction adds a modest 0.003% to AHR’s outstanding share count (based on ~100 million shares outstanding, if unchanged), limiting any dilution concerns. From a governance perspective, incremental ownership can further align the director’s incentives with shareholder interests.
American Healthcare REIT (AHR) filed a Form 4 disclosing that director Scott A. Estes received 3,042 restricted common shares on June 25 2025 upon his re-election to the board.
The grant was made at $0 cost and will vest on June 25 2026. Following the award, Estes' direct ownership increased to 18,895 shares, implying the new grant represents roughly 19 % of his post-transaction holdings.
No derivative securities, sales, or open-market purchases were reported, and the filing contains no additional financial information or risk disclosures.
American Healthcare REIT (NYSE:AHR) filed a Form 4 disclosing that Non-Executive Chairman and Director Jeffrey T. Hanson received 3,042 restricted common shares on 25 Jun 2025 following his re-election to the board. The grant was made at $0 cost and will vest in full on 25 Jun 2026.
Post-transaction, Hanson holds 41,808 shares directly and 85,163 shares indirectly through family trusts, retirement accounts and pension plans, bringing his total reported beneficial ownership to roughly 126,971 AHR shares. The filing also notes that securities held by NCT-107, LLC—a charitable foundation in which Hanson lacks pecuniary interest—will no longer be included in his Section 16 reports.
Form 144 Notice filed by Stefan K.L. Oh, an officer of American Healthcare REIT, indicating a proposed sale of 3,860 shares of common stock with an aggregate market value of $138,689.80 on the NYSE. The sale is scheduled for June 27, 2025.
The securities were originally acquired through an open market purchase on February 2, 2015, with cash payment. The company's total shares outstanding are 159,496,793. The sale will be executed through Charles Schwab & Co.
Key points:
- Sale represents approximately 0.002% of total shares outstanding
- Average price per share: $35.93
- No other securities were sold by the officer in the past 3 months
- Officer confirms no knowledge of undisclosed material adverse information
American Healthcare REIT (NYSE:AHR) filed an 8-K disclosing results from its June 25, 2025 Annual Meeting.
- Nine directors were re-elected for one-year terms ending in 2026.
- Shareholders ratified Deloitte & Touche LLP as independent auditor for FY 2025 (138.4 M for / 1.1 M against).
- Say-on-pay for 2024 executive compensation passed (109.3 M for / 7.5 M against).
- The 2025 Manager Equity Plan was approved (112.6 M for / 4.3 M against).
No other matters were brought to a vote.
On June 20, 2025, American Healthcare REIT, Inc. (NYSE: AHR) filed a Form 8-K to announce its second-quarter 2025 cash distribution.
The board authorized a quarterly dividend of $0.25 per common share, equal to an annualized rate of $1.00. Shareholders of record at the close of business on June 30, 2025, will receive the payment on or about July 18, 2025, funded solely from legally available funds.
No additional financial results, transactions, or strategic updates were disclosed in this report.